We observed that the expression level of c-met was inversely correlated with miR-139-5p expression in NSCLC patients, suggesting miR-139-5p potentially inhibits c-met gene and mRNA expression (Figure 5A). The gene discussed is MET; the disease is non-small cell lung carcinoma.